Comparative study of adjuvant chemotherapeutic efficacy of docetaxel plus cyclophosphamide and doxorubicin plus cyclophosphamide in female breast cancer

PURPOSE: This retrospective study presents a comparative analysis of the overall survival and toxicities, as side effects, of docetaxel plus cyclophosphamide (TC) and doxorubicin plus cyclophosphamide (AC). The study measured their efficacies during adjuvant chemotherapy, treating Pakistani breast c...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Cancer Manag Res
Auteurs principaux: Adeel, Muhammad, Asif, Muhammad, Faisal, Muhammad Naeem, Chaudary, Muhammad Hasanain, Malik, Muhammad Sheraz, Khalid, Muhammad
Format: Artigo
Langue:Inglês
Publié: Dove Medical Press 2019
Sujets:
Original Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6339652/
https://ncbi.nlm.nih.gov/pubmed/30697066
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S180802
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires